UPDATE: Morgan Stanley Reiterates On Pharmacyclics Following IMS Launch Analysis
May 27, 2014 at 09:55 AM EDT
In a report published Tuesday, Morgan Stanley analyst Matthew Harrison reiterated an Equal-Weight rating on Pharmacyclics (NASDAQ: ...